Flavin Financial Services’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.75M Buy
4,831
+1,068
+28% +$366K 1% 35
2026
Q1
$1.32M Sell
3,763
-21
-0.6% -$7.49K 0.89% 38
2025
Q4
$1.24M Sell
3,784
-270
-7% -$85.6K 0.85% 40
2025
Q3
$1.14M Buy
4,054
+768
+23% +$223K 0.81% 40
2025
Q2
$917K Sell
3,286
-325
-9% -$92.1K 0.89% 41
2025
Q1
$1.13M Buy
3,611
+342
+10% +$101K 1.03% 37
2024
Q4
$852K Buy
+3,269
New +$970K 0.81% 43

Other funds holding AMGN

Flavin Financial Services's AMGN Position: Q2 2026 in Review

Flavin Financial Services increased its Amgen (AMGN) stake by 28% in Q2 2026, buying an estimated $366K and bringing the position to 4,831 shares worth $1.75M. The position accounts for 1% of the portfolio, ranked #35.

Flavin Financial Services first reported a position in AMGN in Q4 2024 and has held it in 7 quarters since. 3,157 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Flavin Financial Services held 4,831 shares of Amgen worth $1.75M as of Q2 2026.
  • Flavin Financial Services bought 1,068 Amgen shares in Q2 2026, an estimated $366K.
  • Amgen made up 1% of Flavin Financial Services's portfolio in Q2 2026, its #35 holding.
  • Flavin Financial Services first reported a position in Amgen in Q4 2024 and has held it in 7 quarters since.
  • 3,157 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Flavin Financial Services's 13F filing for Q2 2026, filed 13 Aug 2026.